Windtree Therapeutics, Inc.
WINT
$0.05
$0.00-5.74%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -33.10% | 13.40% | -15.43% | -9.29% | 7.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -20.86% | -65.21% | -7.15% | -17.61% | 1.09% |
| Operating Income | 20.86% | 65.21% | 7.15% | 17.61% | -1.09% |
| Income Before Tax | -954.40% | 10.11% | -139.15% | 152.19% | 32.45% |
| Income Tax Expenses | -1,329.58% | -- | -- | -- | -- |
| Earnings from Continuing Operations | -921.64% | 11.59% | -139.58% | 153.69% | 37.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -921.64% | 11.59% | -139.58% | 153.69% | 37.88% |
| EBIT | 20.86% | 65.21% | 7.15% | 17.61% | -1.09% |
| EBITDA | 28.14% | 65.29% | 7.09% | 17.67% | -0.94% |
| EPS Basic | 99.49% | 99.71% | -- | -- | -- |
| Normalized Basic EPS | 99.67% | 99.79% | -- | -- | -- |
| EPS Diluted | 99.49% | 99.71% | -- | -- | -- |
| Normalized Diluted EPS | 99.67% | 99.79% | -- | -- | -- |
| Average Basic Shares Outstanding | 150,609.60% | 42,311.30% | -- | -- | -- |
| Average Diluted Shares Outstanding | 150,609.60% | 42,311.30% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 1.00% | -- | -- | -- | -- |